Pregled bibliografske jedinice broj: 1169724
Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results
Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results // The European Association of Nuclear Medicine (EANM)
Düsseldorf, Njemačka, 2018. (poster, međunarodna recenzija, ostalo, stručni)
CROSBI ID: 1169724 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Immunotherapy Response Assessment with F-18 FDG
PET/CT in Metastatic Melanoma: First Results
Autori
Gordana Horvatic Herceg, Luka Simetić, Davorin Herceg, Martina Ciglar-Hlasc, Mario Lusic
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, ostalo, stručni
Izvornik
The European Association of Nuclear Medicine (EANM)
/ - , 2018
Skup
Annual Congress of the European Association of Nuclear Medicine (EANM)
Mjesto i datum
Düsseldorf, Njemačka, 13.10.2018. - 17.10.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
18FDG-PET/CT, melanoma, immunotherapy, pembrolizumab
Sažetak
To explore the utility of the 18FDG-PET/CT for treatment monitoring in patients with metastatic melanoma receiving pembrolizumab.
Izvorni jezik
Engleski
POVEZANOST RADA
